
MUMBAI/NEW DELHI -- At least six Indian pharmaceutical companies have joined the global race to develop a novel coronavirus vaccine, giving a sector better known for making generic copies of drugs a platform to show its innovative capability.
Top player Serum ties up with US company to target product launch by Q2 next year
MUMBAI/NEW DELHI -- At least six Indian pharmaceutical companies have joined the global race to develop a novel coronavirus vaccine, giving a sector better known for making generic copies of drugs a platform to show its innovative capability.
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.